Continuing the Conversation: Improving CAD/PAD Care Through Pharmacist Intervention

Continuing the Conversation: Improving CAD/PAD Care Through Pharmacist Intervention

Faculty Presenter

Sarah A. Spinler, PharmD, FCCP, FASHP, FAHA, AACC
Professor and Chair, Department of Pharmacy Practice
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, New York

Professor Emeritus
Philadelphia College of Pharmacy, University of the Sciences
Philadelphia, Pennsylvania

Medical Writer for Patient Counseling Videos

Jeannette Y. Wick, RPh, MBA, FASCP
Freelance Medical Writer
Arlington, Virginia

Assistant Director, Office of Pharmacy Professional Development
University of Connecticut School of Pharmacy
Storrs, Connecticut
 
Program Description
Together with pharmacologic therapy, lifestyle modification and comorbidity management are key in improving cardiovascular outcomes and quality of life. Patients with atherosclerotic vascular disease will benefit from a variety of risk factor reduction strategies, including smoking cessation, blood pressure control, and weight management. Pharmacists can help patients achieve risk reduction through comorbidity management and through medication therapy management. This activity will focus on the pharmacist’s role in working with the health care team to improve quality of care and outcomes in patients with CAD and PAD. Clinical vignettes highlighting the patient encounter will be presented and assessed by the faculty.

Target audience: Health-system and retail pharmacists
Type of activity: Knowledge
Release date: February 10, 2021
Expiration date: February 10, 2022
Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Outline strategies to effectively discuss coronary artery disease (CAD) and peripheral artery disease (PAD) with patients
• Review important counseling points for patients being treated for CAD/PAD and how they can be actively involved in their own treatment

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-069-H01-P. The activity is available for CE credit through February 10, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Faculty

Sarah A. Spinler, PharmD, FCCP, FASHP, FAHA, AACC, has no financial relationships with commercial interests to disclose.

Medical Writing Support

Jeannette Y. Wick, RPh, MBA, FASCP, has no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Namissa, PharmD, BCPS; Kelly McCormick; Susan Pordon; and Brianna Winters have no financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms